$60,372,420
to TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA, THE
ALZHEIMER'S DISEASE GENETICS CONSORTIUM
Verbatim from USAspending.gov. Capitalization, abbreviations, and codes are unchanged.
What the model surfaced from this award
Obligation under the Alzheimer's Disease Genetics Consortium, an NIH research program that began in 2009 at University of Pennsylvania studying genetic risk factors in Alzheimer's disease.
Supports foundational research on Alzheimer's genetics, potentially informing future therapeutic development and precision-medicine approaches to dementia.
Generated by award_classification v2.1.0 via claude-haiku-4-5-20251001 on 2026-06-07. Cost: $0.020539.
- 2026-04-20ABRAMSON CANCER CENTER OF THE U OF P CORE SUPPORT GRANT$163.2M
- 2026-02-27AWARD OF THE BASE TO UPENN FOR CEIRR CONTRACT 75N93021C00015. THIS CONTRACT WILL SUPPORT THE NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE (CEIRR)$59.3M
- —ARCHES: AUTONOMOUS RESILIENT COGNITIVE HETEROGENEOUS SWARMS$48.5M
- —RESEARCH IN HIGH ENERGY PHYSICS AT THE UNIVERSITY OF PENNSYLVANIA$41.6M
- —PENN PREVENTION CLINICAL TRIALS UNIT$33.0M
- USAspending.gov — all awards for this UEI →
- SAM.gov entity registration →
- Award record ingested from usaspending. Source identifier ASST_NON_U01AG032984_075.
The Buildout does not edit federal records. Any inaccuracy reflects the upstream source; it will update here when corrected there.